Evidence map›Paper›PMID 31683923›Full record

ReviewGenes2019

The

Jesse L Berry, Ashley Polski, Webster K Cavenee, Thaddeus P Dryja, A Linn Murphree, Brenda L Gallie

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. The significance ofFrontiers in immunology · 2024
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Jesse L BerryUSC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA. jesse.berry@med.usc.edu.ORCID 0000-0002-8907-9100
Ashley PolskiUSC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA. ashley.polski@usc.edu.ORCID 0000-0001-6301-6892
Webster K CaveneeLudwig Institute for Cancer Research, University of California, San Diego, CA 92093, USA. wcavenee@ucsd.edu.
Thaddeus P DryjaCogan Eye Pathology Laboratory, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA 02114, USA. thaddeus_dryja@meei.harvard.edu.
A Linn MurphreeUSC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA. alm4@mac.com.
Brenda L GallieDepartment of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON M5T 3A9, Canada. brenda@gallie.ca.ORCID 0000-0002-9697-9211
University of Southern California · USMassachusetts Eye and Ear Infirmary · USUniversity of California San Diego · USUniversity of Toronto · CA

Funding

Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes.K08CA232344 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI BERRY, JESSE L · 2018 to 2022
$1.1M
NCI NIH HHS K08 CA232344
6 · The paper itself

Abstract

The

Indexed as

Genes, Tumor SuppressorBiomarkers, TumorCloning, MolecularHumansRetinoblastomaRetinoblastoma Binding ProteinsUbiquitin-Protein LigasesBiomarkers, TumorRB1 protein, humanRetinoblastoma Binding ProteinsUbiquitin-Protein Ligasescancer geneticsgene cloninggenetic testingretinoblastomatumor suppressor gene

Identifiers

PMID31683923
PMCPMC6895859
OpenAlexW2985894798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.